RxDoctor Payments Data

Hannan Qureshi, MD

Otolaryngology · Marietta, GANPI 1942691910

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,626 of the $3,935 with a category attached, or 66.7%. 16 manufacturers reported payments, led by Aerin Medical Inc. at 49.9% of the total.

$3,935in general payments, 2019–2025

Across 56 payments — averaging $70.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$2K
  • Regeneron Healthcare Solutions, Inc.$411
  • GSK$260
  • Sanofi$199
  • Integra Lifesciences Corporation$150
  • Neurent Medical Limited$139
  • plus $812 from 10 others

What the payments were for

  • Travel & lodging$1,30933%
  • Food & beverage$2,62667%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,935 in reported general payments places this provider in the 80th percentile of 308 otolaryngology providers in Georgia.

See all otolaryngology providers in Georgia

Medicare billing

Part B allowed, 2024
$126,140
Medicare patients
275
Services billed
972

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide69$2,088
Fluticasone Propionate43$552
Ofloxacin25$525
Methylprednisolone49$473
Famotidine39$431
Omeprazole34$331
Mupirocin33$234
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav28$218
Doxycycline Hyclate20$179
Betamethasone Valerate11$166

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Marietta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →